AVEIR DR Coverage With Evidence Development (CED) Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAbbott Medical Devices
About this trial
The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the dual chamber Aveir Leadless Pacemaker device (aka Aveir™ DR LP system).
Eligibility criteria
Qualifiers
Medicare beneficiaries implanted with an Aveir DR leadless pacemaker on or after the study start date (i.e., the date of Aveir DR market approval) will be included in the study.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Aveir DR Leadless Pacemaker System
- Dual Chamber Transvenous Pacemaker
Treatment groups
2,812 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov